Publication: Bioprinting of exosomes
| dc.contributor.coauthor | Sarısözen, Buğra | |
| dc.contributor.department | Graduate School of Sciences and Engineering | |
| dc.contributor.department | Graduate School of Health Sciences | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.department | KUTTAM (Koç University Research Center for Translational Medicine) | |
| dc.contributor.kuauthor | Hosseinikarimi, Nasır Seyed | |
| dc.contributor.kuauthor | Oğuz, Ferdi | |
| dc.contributor.kuauthor | Sokullu, Emel | |
| dc.contributor.schoolcollegeinstitute | GRADUATE SCHOOL OF HEALTH SCIENCES | |
| dc.contributor.schoolcollegeinstitute | GRADUATE SCHOOL OF SCIENCES AND ENGINEERING | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.contributor.schoolcollegeinstitute | Research Center | |
| dc.date.accessioned | 2026-07-02T07:28:54Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Exosomes (EXOs) help cells communicate by transporting proteins, lipids, and RNA. EXOs are being studied for diagnosis and treatment in oncology, regenerative medicine, and infectious diseases. EXOs' research is limited because isolating high-purity EXOs in sufficient quantities impairs their therapeutic value. Bioprinting, which uses 3D printing to produce complex living objects, opens new avenues for medical research. 3D bioprinting can overcome limitations in EXO research. Bioprinting-customized microenvironments can imitate the natural biological setting, increasing the production of EXOs and their research. Bioprinting has enabled the development of precise, reproducible 3D models to study EXOs' dynamics in a controlled setting. In three dimensions, bioprinted tissues can be used to study how EXOs affect cell-to-cell communication and disease progression. Additionally, bioprinted tissue models are essential for EXO-based therapeutic safety and efficacy testing. EXO bioprinting advances EXO isolation and application, clarifying their functions and therapeutic potential. Scientists enhance the scalability and precision of EXO production via bioprinting. By improving individualized EXO therapies, sophisticated printed models could revolutionize personalized medicine. Bioprinting technology is projected to revolutionize EXO modification and application, revolutionizing disease treatment and regenerative medicine. Overall, an emerging area of inquiry with great potential for cutting-edge biomedical research is presented, offering hope for more efficient therapeutic approaches leveraging Exos' biological processes. | |
| dc.description.fulltext | No | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | WOS | |
| dc.description.indexedby | Scopus | |
| dc.description.indexedby | PubMed | |
| dc.description.openaccess | hybrid | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.version | Published Version | |
| dc.identifier.WoSQuartile | Q2 | |
| dc.identifier.doi | 10.1039/d5bm01754h | |
| dc.identifier.eissn | 2047-4849 | |
| dc.identifier.embargo | No | |
| dc.identifier.issn | 2047-4830 | |
| dc.identifier.issue | 9 | |
| dc.identifier.pubmed | 41853937 | |
| dc.identifier.scopus | 2-s2.0-105033164984 | |
| dc.identifier.uri | https://doi.org/10.1039/d5bm01754h | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/32969 | |
| dc.identifier.volume | 14 | |
| dc.identifier.wos | 001718499400001 | |
| dc.keywords | Exosomes | |
| dc.keywords | Bioprinting | |
| dc.keywords | Personalized medicine | |
| dc.language | eng | |
| dc.publisher | Royal Society of Chemistry | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | Biomaterials Science | |
| dc.relation.openaccess | N/A | |
| dc.rights | N/A | |
| dc.rights.uri | N/A | |
| dc.subject | Biomaterials | |
| dc.title | Bioprinting of exosomes | |
| dc.type | Review | |
| dspace.entity.type | Publication | |
| relation.isOrgUnitOfPublication | 3fc31c89-e803-4eb1-af6b-6258bc42c3d8 | |
| relation.isOrgUnitOfPublication | 2f870f28-12c9-4b28-9465-b91a69c1d48c | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication | 91bbe15d-017f-446b-b102-ce755523d939 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 3fc31c89-e803-4eb1-af6b-6258bc42c3d8 | |
| relation.isParentOrgUnitOfPublication | 4c75e0a5-ca7f-4443-bd78-1b473d4f6743 | |
| relation.isParentOrgUnitOfPublication | 434c9663-2b11-4e66-9399-c863e2ebae43 | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication | d437580f-9309-4ecb-864a-4af58309d287 | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 4c75e0a5-ca7f-4443-bd78-1b473d4f6743 |
